The lipid accumulation product as a useful index for identifying abnormal glucose regulation in young Korean women

Diabetic Medicine

Volumn 30, Issue 4, 2013, Pages 436-442

  Oh, Jee Young ^a   Sung, Y A ^a   Lee, H J ^a  

^a Ewha Womans University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; KOREAN (PEOPLE); LIPID ACCUMULATION PRODUCT INDEX; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PREVALENCE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; ADOLESCENT; BLOOD; DIET RESTRICTION; EVALUATION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; METABOLISM; METHODOLOGY; PHYSIOLOGY;

ADOLESCENT; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; FASTING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; TRIGLYCERIDES; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84883541239     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12052     Document Type: Article

References (26)

1. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 2005; 2: 95–300.
2. Lemieux I, Alméras N, Mauriège P, Blanchet C, Dewailly E, Bergeron J et al. Prevalence of ‘hypertriglyceridemic waist’ in men who participated in the Quebec Health Survey: Association with atherogenic and diabetogenic metabolic risk factors. Can J Cardiol 2002; 18: 725–732.
3. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Alméras N et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000; 102: 179–184.
4. St-Pierre J, Lemieux I, Vohl MC, Perron P, Tremblay G, Després JP et al. Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease. Am J Cardiol 2002; 90: 15–18.
5. Sam S, Haffner S, Davidson MH, D’Agostino RB, Feinstein S, Kondos G et al. Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes. Diabetes Care 2009; 32: 1916–1920.
6. Kahn HS, Valdez R. Metabolic risks identified by the combination of enlarged waist and elevated triacyglycerol concentration. Am J Clin Nutr 2003; 78: 928–934.
7. Kahn HS. The ‘lipid accumulation product’ performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord 2005; 5: 26–35.
8. Kahn HS. The lipid accumulation product is better than BMI for identifying diabetes. A population-based comparison. Diabetes Care 2006; 9: 151–153.
9. Bozorgmanesh M, Hadaegh F, Azizi F. Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study. Lipids Health Dis 2010; 9: 45–53.
10. Ioachimescu AG, Brennan DM, Hoar BM, Hoogwerf BJ. The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS Database Study. Obesity 2010; 18: 1836–1844.
11. Taverna MJ, Martínez-Larrad MT, Frechtel GD, Serrano-Ríos M. Lipid accumulation product: a powerful marker of metabolic syndrome in a healthy population. Eur J Endocrinol 2011; 164: 559–567.
12. Hughes VA, Roubenoff R, Wood M, Frontera WR, Evans WJ, Fiatarone Singh MA. Anthropometric assessment of 10-year changes in body composition in the elderly. Am J Clin Nutr 2004; 80: 475–482.
13. Han TS, McNeill G, Seidell JC, Lean ME. Predicting intra-abdominal fatness from anthropometric measures: the influence of stature. Int J Obes Relat Metab Disord 1997; 21: 587–593.
14. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012; 35: S64–S71.
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.
16. Wehr E, Pilz S, Boehm BO, März W, Obermayer-Pietsch B. The lipid accumulation product is associated with increased mortality in normal weight postmenopausal women. Obesity 2011; 19: 1873– 1880.
17. Wehr E, Gruber HJ, Giuliani A, Möller R, Pieber TR, Obermayer-Pietsch B. The lipid accumulation product is associated with impaired glucose tolerance in PCOS women. J Clin Endocrinol Metab 2011; 96: E986–E990.
18. Wiltgen D, Benedetto IG, Mastella LS, Spritzer PM. Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome. Hum Reprod 2009; 24: 1726– 1731.
19. Kim DJ. The epidemiology of diabetes in Korea. Diabetes Metab J 2011; 35: 303–308.
20. Rhee SY, Woo JT. The prediabetic period: review of clinical aspects. Diabetes Metab J 2011; 35: 107–116.
21. Kim Y, Suh YK, Choi H. BMI and metabolic disorders in South Korean adults: 1998 Korea National Health and Nutrition Survey. Obes Res 2004; 12: 445–453.
22. Ruderman NB, Schneider SH, Berchtold P. The ‘metabolically obese’, normal-weight individuals. Am J Clin Nutr 1981; 34: 1617– 1621.
23. American Diabetes Association. Consensus development conference on insulin resistance. Diabetes Care 1998; 21: 310–314.
24. Brisson D, Perron P, Guay S-P, Gaudet D, Bouchard L. The ‘hypertriglyceridemic waist’ phenotype and glucose intolerance in pregnancy. CMAJ 2010; 182: E722–E725.
25. Balion CM, Raina PS, Gerstein HC, Santaguida PL, Morrison KM, Booker L et al. Reproducibility of impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) classification: a systematic review. Clin Chem Lab Med 2007; 45: 1180–1185.
26. De Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CD et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. J Am Med Assoc 2001; 285: 2109–2113.